Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

During the Trading Day
37.20 -1.12 / -2.92%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.09 -0.11 / -0.30%
 
Volume: 10.9K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$5.9B

Company Description

Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. It markets a portfolio of products in arthritis, inflammation and orphan diseases. The company was founded on December 20, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Horizon Pharma Plc
Connaught House, 1st Floor
Dublin Dublin 4
P:(531) 772-2100
Investor Relations:
(224) 383-3285

Employees

Shareholders

Mutual fund holders34.91%
Other institutional28.74%
Individual stakeholders1.67%

Top Executives

Timothy P. WalbertChairman, President & Chief Executive Officer
Robert W. MetzSVP-Business Operations & Government Affairs
Paul W. HoelscherChief Financial Officer & Executive Vice President
Amy GrahnSVP-Global Clinical Development & Operations
John DevaneChief Scientific Officer & Senior Vice President